Mexico approves emergency use of Pfizer coronavirus vaccine
The Mexican government's medical safety commission approved the emergency use of the Pfizer-BioNTech coronavirus vaccine Friday, making Mexico the fourth country to do so.
Assistant Health Secretary Hugo López-Gatell said Mexico's approval came after Britain, Canada and Bahrain. The United States announced its own approval of the vaccine shortly after Mexico.
Mexico is set to receive 250,000 doses of the vaccine, enough for 125,000 people, because each person requires two shots. López-Gatell has said that front-line health workers will get the shots first.
Vaccinations are expected to begin as soon as next week. López-Gatell said the approval "is of course a reason for hope," though the initial rounds of shots are not nearly enough for Mexico's estimated 1.6 million health care workers.
López-Gatell downplayed reports of allergic reactions among some vaccine recipients in Britain, noting that "the immense, immense, immense majority of people in Mexico and the world will be able to take this vaccine."
Mexico posted a record increase of 12,253 coronavirus cases Friday, for a total of 1,229,379 infections during the pandemic.
Officials also reported 693 more deaths related to COVID-19, bringing the country's total to 113,019. However, even official estimates place the real death toll at closer to 150,000, due to Mexico's extremely low level of testing.
Mexico City has become the central focus of increasing cases in the country. The capital's hospitals were 78% full Friday, a level that worried officials.
Mayor Claudia Sheinbaum issued an urgent appeal for residents of the capital to stay home, saying the city of almost 9 million was in a "coronavirus emergency."
López-Gatell called it an "extremely urgent" situation.
Mexico approves emergency use of Pfizer coronavirus vaccine (2020, December 12)
retrieved 27 September 2023
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.